| Literature DB >> 30279587 |
Li-Fang Zhu1,2, Zhi-Cheng Yao1,2, Zeeshan Ahmad3, Jing-Song Li2, Ming-Wei Chang4,5.
Abstract
Chitosan is an extremely valuable bioEntities:
Mesh:
Substances:
Year: 2018 PMID: 30279587 PMCID: PMC6168458 DOI: 10.1038/s41598-018-33088-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Figure 1Digital image of Ganoderma lucid powder.
Figure 2The effect of deacetylation and SEM images of GLSP, C-T and C-U (a) GLSP SEM (b) SEM of C-T (c) SEM of C-U, and the effect of deacetylation time on DD, [η] and using TCD (d) and USAD (e). C-U sample was generated using USCD setup as: 90 W, 15 min, 20 w/v% NaOH, 1:15 (g: mL).
Figure 3FTIR spectra of C-C, C-T and C-U (a); XRD analysis of GLSP, C-T and C-U (b).
The DD, CrI and 2θ of GLSP, C-T and C-U.
| Sample | Results | ||
|---|---|---|---|
| DD (%) | CrI (%) | 2θ (°) | |
| GLSP | 25.1 | 56.8 | 20.2, |
| C-T | 85.1 | 24.6 | 20.2, 27.5, 31.9, 45.7, 56.6 |
| C-U | 82.2 | 27.5 | 20.2, 27.5, 31.9, 45.6, 56.5 |
Figure 4TGA analysis for GLSP, C-T and C-U. (a) Change in residual weight vs. temperature, (b) derivative weight vs. temperature.
Figure 5Cell viability evaluation. (a) Effects of GLSP/C-T/C-U/C-C with different concentration (1 mg/mL, 0.1 mg/mL, 0.01 mg/mL) on the L 929 cell viability using CCK-8 assay (b–d) SEM images of L929 cell morphology treated by GLSP/C-U/C-T (1 mg/mL). Each treatment condition was repeated using 8 wells (96-well plate).
Figure 6Biocompatibility assay using L929 cell. (a1–a4) Merged fluorescent images of L929 cell morphology treated by C-C/GLSP/C- U /C- T (1 mg/mL); (a1′–a4′) bright-field fluorescent image of (b1–b4) respectively.
Figure 7Effect of antibacterial activity assay. (a1) Violet red bile agar plate. (a2) Antibacterial effect of GLSP, C-T and C-U on E. coli post 24 h inoculation at 37 °C (b1) baird-parker agar plate. (b2) Antibacterial effect of GLSP, C-T and C-U on S. aureus post 24 h inoculation at 37 °C (a3 and b3) antibacterial effect of C-C on E. coli and S. aureus, respectively.
Inhibition zone obtained using agar plates method against E. coli and S. aureus.
| Sample | Inhibition zone diameter (Mean ± SD, mm) | ||
|---|---|---|---|
|
|
| Level | |
| GLSP | 0 | 0 | / |
| C-T | 16.9 ± 0.1 | 16.4 ± 0.2 | * |
| C-U | 23.8 ± 0.1 | 21.3 ± 0.1 | ** |
| C-C | 43.8 ± 0.2 | 21.1 ± 0.3 | ** |
*Very sensitive, **extremely sensitive.
Figure 8Fluorescence microplate reader analysis of membrane permeability. (a) Staining of E. coli using Pi and FDA (b) staining of S. aureus using Pi and FDA; 0.4 mL inoculum containing ~1.5 × 106 CFU/mL of either E. coli or S. aureus were incubated in each well (96-well plate) at 37 °C for 24 h. Identical concentration of chitosan (1 mg/mL) was added to each well. Eight wells were measured from each test group, **p < 0.01, *p < 0.05.